Dosage and Adverse Effects of Topical Tacrolimus and Steroids in Daily Management of Atopic Dermatitis-Reference-Cited by-同舟云学术

Dosage and Adverse Effects of Topical Tacrolimus and Steroids in Daily Management of Atopic Dermatitis

Published:2004-04 Issue:4 Volume:31 Page:277-283
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:The Journal of Dermatology

Author:

Furue Masutaka¹,Terao Hiroshi¹,Moroi Yoichi¹,Koga Tetsuya¹,Kubota Yumiko²,Nakayama Juichiro²,Furukawa Fukumi³,Tanaka Yoichi⁴,Katayama Ichiro⁴,Kinukawa Naoko⁵,Nose Yoshiaki⁵,Urabe Kazunori¹

Affiliation:

1. Department of Dermatology; Kyushu University; Fukuoka Japan

2. Department of Dermatology; Fukuoka University; Fukuoka Japan

3. Department of Dermatology; Wakayama Medical University; Wakayama Japan

4. Department of Dermatology; Nagasaki University; Nagasaki Japan

5. Department of Medical Information Science; Kyushu University; Fukuoka Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1346-8138.2004.tb00673.x/fullpdf

Reference18 articles.

1. Is the prevalence of atopic dermatitis increasing?;Williams;Clin Exp Dermatol,1992

2. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood;Williams;J Allergy Clin Immunol,1999

3. Increase of atopic dermatitis (AD) in recent Japan;Takeuchi;Envir Dermatol,2000

4. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: Comparison with the disease frequency examined 20 years ago;Sugiura;Acta Dermato-Venereologica,1998

5. Atopic dermatitis (disseminated neurodermatitis) of young adults;Brunsting;Arch Derm Syph,1936

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs;International Journal of Molecular Sciences;2024-08-28

2. Dupilumab Treatment in Pediatric Patients Aged 6–11 Years with Severe Atopic Dermatitis Whose Disease Is Not Adequately Controlled: A Review;Drug Design, Development and Therapy;2024-02

3. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis;The Journal of Allergy and Clinical Immunology: In Practice;2023-05

4. Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis;JAMA Dermatology;2023-03-01

5. English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021;The Journal of Dermatology;2022-08-22